CStone Pharmaceuticals (FRA:PH4)
Germany · Delayed Price · Currency is EUR 0.5700
0.00 (0.00%)
At close: Jan 2, 2026
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of €940.18 million as of January 9, 2026. Its market cap has increased by 122.00% in one year.
Market Cap
940.18M
Enterprise Value
904.08M
Revenue
24.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.57
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 1.42B to 940.18M, a decrease of -33.72%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 940.18M | 10.73% |
| Dec 31, 2025 | 849.07M | 132.56% |
| Dec 31, 2024 | 365.09M | 9.00% |
| Dec 29, 2023 | 334.93M | -49.41% |
| Dec 30, 2022 | 662.04M | -39.03% |
| Dec 31, 2021 | 1.09B | -11.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |